Why the study?
Does intranasal nitroglycerin attenuate the cardiovascular response to laryngoscopy and intubation in patients undergoing coronary artery bypass surgery?
Does intranasal nitroglycerin attenuate the cardiovascular response to laryngoscopy and intubation in patients undergoing coronary artery bypass surgery?
Intranasal nitroglycerin effectively attenuates the pressor response to laryngoscopy and intubation in patients undergoing CABG, proving more effective than intravenous lignocaine.
Supports intranasal nitroglycerin to blunt intubation responses in CABG; confirms superiority to lignocaine in this RCT.
The effect of intranasally administered nitroglycerin (NTG) on the cardiovascular response to laryngoscopy and intubation was studied. Thirty patients scheduled to undergo coronary artery by-pass surgery under thiopentone, enflurane and pancuronium anaesthesia were randomly divided into three groups. Group I received lignocaine 1.5 mg/kg i.v. prior to laryngoscopy and intubation (control group). Group II received lignocaine 1.5 mg/kg i.v. and in addition 2 mg nitroglycerin (NTG) was given intranasally. Group III received only 2 mg NTG intranasally. In Group I laryngoscopy and intubation caused a significant increase in mean arterial pressure (MAP) (P less than 0.01), heart rate (HR) (P less than 0.01) and rate pressure product (RPP) (P less than 0.01) compared to preoxygenation values. In Group II and III MAP and RPP remained unchanged, whereas HR increased (P less than 0.01 and P less than 0.01 respectively). It can be concluded that intranasally administered NTG effectively attenuates the pressor response to laryngoscopy and intubation in patients presenting for coronary artery by-pass surgery and that it is more effective and convenient method than intravenous lignocaine.
No takes yet. Share an insight, caveat, or question.
Dich‐Nielsen et al. (1986) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: